In 2022, the House Committee on Ethics announced it would extend its investigation of allegations of failing to disclose stock transactions. In July of 2022, the Committee unanimously voted to dismiss the referral.
Timeline
February 28, 2022Office of Congressional Ethics
recommended further review by the House Committee on Ethics